Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 3 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Carcinoma, Hepatocellular 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × fluorocholine × Clear all
NCT04391348 2023-11-18

PET-HCC01

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
230 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04340765 2020-04-13

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

Buddhist Tzu Chi General Hospital

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT01993160 2017-01-13

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

University Health Network, Toronto

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡